ADHD drug delivery specialist Cingulate hit with manufacturing-related FDA rejection

After submitting its timed-release version of a decades-old ADHD drug to the FDA nearly a year ago, Kansas City's Cingulate has suffered a setback in its bid to commercialize its first product.&nbs | Cingulate will need to take a detour to win its first FDA approval, as the agency has rejected its lead candidate over manufacturing concerns.

Raccontata dafiercepharma.com